WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence “within three to four weeks” – as soon as DRC regulators issue their own approval, said WHO’s Science Director Meg Doherty, at a Wednesday […] Continue reading ->
In the late 1990s, doctors treating sleeping sickness, a parasitic disease spread by tsetse flies that is almost always fatal without treatment, still relied on melarsoprol, an arsenic-based drug that killed roughly one patient in 20. One patient given melarsoprol in 2003 later recalled the injection “felt like fire” being injected into his veins, turning […] Continue reading ->
Speaking at a flagship World Health Summit panel global health officials and pharmaceutical executives urged governments to reframe pandemic preparedness as ‘biodefence’ – a core national security asset and not a discretionary health expenditure. BERLIN – That strategic pivot is becoming urgent as both global health and aid budgets shrink and multilateral diplomacy on pandemic […] Continue reading ->
The United Nations General Assembly adopted the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR) by a substantial majority at a plenary meeting in New York on Monday, with 153 countries voting in favor and only three against. The declaration went to a vote after the UN High-Level Meeting on 25 September could not […] Continue reading ->
After months of speculation, prospective candidates in the race to become the next Director-General of the World Health Organization (WHO) are now emerging. At the same time, member states have launched a process to review the global health architecture, with the aim of clarifying roles, strengthening coordination, and aligning financing more closely with national, regional, […] Continue reading ->
Luis Pizarro, Unitaid’s newly-appointed Executive Director comes to the organization with sizeable depth and breadth of experience – as the leader of Geneva’s Drugs for Neglected Diseases Initiative (DNDi) and before that, leadership of ventures in Africa, Asia and the Americas. However, his main challenge at Unitaid will be steadying the financially troubled organization, which […] Continue reading ->
As artificial intelligence drives rapid health innovations, global guardrails, equitable data, and local capacity are needed to ensure equitable progress. To address this, a landmark framework launched by three United Nations agencies lays out a strategic roadmap for innovators. Meanwhile, health leaders emphasise that lower-income regions must become co-creators of future innovations. New guidelines for […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->
WHO emergency funds are running low, and global health leaders are concerned about a systemic paralysis in pandemic preparedness. In high-level discussions in Geneva, experts explored the geopolitical rifts, pitting the Global South’s demand to treat pandemic tools as legally binding “public goods” against a European push for market-driven surge financing. As a severe Ebola […] Continue reading ->
The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading ->